Association of metabolic complications with plasma mid-regional pro-adrenomedullin level in stable kidney transplant recipients.

Yosuke Suzuki,Fumihiko Katagiri,Fuminori Sato,Takashi Fujioka,Ryota Tanaka,Yuhki Sato,Hiromitsu Mimata,Hiroki Itoh

Clinica Chimica Acta（2016）

引用 0|浏览2

暂无评分

摘要

•Kidney transplant recipients at least 180days after transplantation were studied.•Anti-hypertensive treatment intensity and use of lipid-lowering agents are associated with MR-proADM.•MR-proADM may be a useful biomarker for metabolic disorders in stable kidney transplant recipients.

查看译文

关键词

Mid-regional pro-adrenomedullin,Metabolic complications,Hypertension,Hyperlipidemia,Kidney transplantation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要